INTCO Medical
1
17M
1
0.08
- Areas of investment
Summary
INTCO Medical is the famous Corporate Investor, which was founded in 2009. The main department of described Corporate Investor is located in the Zibo. The company was established in Asia in China.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Service Industry, Medical Device. Among the most popular portfolio startups of the fund, we may highlight LyncMed.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the INTCO Medical, startups are often financed by Yunqi Partners. The meaningful sponsors for the fund in investment in the same round are Yunqi Partners, Chunxiao Capital. In the next rounds fund is usually obtained by Yunqi Partners, VisionMax Health Fund, InnoVen Capital.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.08
- Investments by industry
- Medical Device (1)
- Service Industry (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| LyncMed | 02 Apr 2018 | Medical Device, Service Industry | Early Stage Venture | 17M | China, Beijing, Dongcheng District |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.